{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:26:51Z","timestamp":1793957211792,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107922","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:56:49Z","timestamp":1789196209000},"page":"107922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Platelet-activating factor in multiple sclerosis: From peripheral inflammation to central neurodegeneration"],"prefix":"10.1016","volume":"115","author":[{"given":"Abdullah","family":"Baothman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7883-5034","authenticated-orcid":false,"given":"Weam A.","family":"Elkady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0979-556X","authenticated-orcid":false,"given":"Arafa","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-425X","authenticated-orcid":false,"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msard.2026.107922_bib0001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2443.2000.00333.x","article-title":"Interaction between neurone and microglia mediated by platelet-activating factor","volume":"5","author":"Aihara","year":"2000","journal-title":"Genes. Cells"},{"issue":"4","key":"10.1016\/j.msard.2026.107922_bib0002","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1523\/JNEUROSCI.1171-15.2016","article-title":"Platelet-activating factor receptors mediate excitatory postsynaptic hippocampal injury in experimental autoimmune encephalomyelitis","volume":"36","author":"Bellizzi","year":"2016","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.msard.2026.107922_bib0003","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0165-5728(98)00246-X","article-title":"Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing\u2013remitting multiple sclerosis","volume":"94","author":"Callea","year":"1999","journal-title":"J. Neuroimmunol."},{"issue":"10512","key":"10.1016\/j.msard.2026.107922_bib0004","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(25)01039-6","article-title":"Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"406","author":"Chataway","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.msard.2026.107922_bib0005","first-page":"213","article-title":"Reduced sensitivity of human platelets to PAF-acether following ticlopidine intake","volume":"19","author":"Chignard","year":"1989","journal-title":"Haemostasis"},{"issue":"7","key":"10.1016\/j.msard.2026.107922_bib0006","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jnen\/nly032","article-title":"Platelets drive inflammation and target gray matter and the retina in autoimmune-mediated encephalomyelitis","volume":"77","author":"D'Souza","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.msard.2026.107922_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1207237","article-title":"Role of micronutrients in the modulation of immune system and platelet activating factor in patients with COVID-19; a narrative review","volume":"10","author":"Doaei","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.msard.2026.107922_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105900","article-title":"Phytochemical profiling and mechanistic evaluation of black garlic extract on multiple sclerosis rat model","volume":"111","author":"Elkhawas","year":"2023","journal-title":"J. Funct. Foods."},{"key":"10.1016\/j.msard.2026.107922_bib0009","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jff.2017.12.068","article-title":"Neuroprotective effect of S-allyl cysteine on an experimental model of multiple sclerosis: antioxidant effects","volume":"42","author":"Escribano","year":"2018","journal-title":"J. Funct. Foods."},{"key":"10.1016\/j.msard.2026.107922_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108672","article-title":"Serum phospholipidomics reveals altered lipid profile and promising biomarkers in multiple sclerosis","volume":"697","author":"Ferreira","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.msard.2026.107922_bib0011","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jsbmb.2018.11.013","article-title":"Vitamin D attenuates rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAFR) in respiratory epithelial cells","volume":"187","author":"Greiller","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.msard.2026.107922_bib0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.explore.2005.10.007","article-title":"The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial","volume":"2","author":"Johnson","year":"2006","journal-title":"Explore"},{"issue":"6","key":"10.1016\/j.msard.2026.107922_bib0013","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1084\/jem.20050660","article-title":"Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor","volume":"202","author":"Kihara","year":"2005","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.msard.2026.107922_bib0014","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/jcm8020162","article-title":"Platelet depletion is effective in ameliorating anxiety-like behavior and reducing the pro-inflammatory environment in the hippocampus in murine experimental autoimmune encephalomyelitis","volume":"8","author":"Kocovski","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107922_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1515\/revneuro-2012-0062","article-title":"Multiple sclerosis and glutamate excitotoxicity","volume":"24","author":"Kostic","year":"2013","journal-title":"Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.msard.2026.107922_bib0016","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/CIRCRESAHA.111.256370","article-title":"Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis","volume":"110","author":"Langer","year":"2012","journal-title":"Circ. Res."},{"issue":"23","key":"10.1016\/j.msard.2026.107922_bib0017","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.3390\/molecules24234414","article-title":"Forty years since the structural elucidation of platelet-activating factor (PAF): historical, current, and future research perspectives","volume":"24","author":"Lordan","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.msard.2026.107922_bib0018","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1352458506071213","article-title":"Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial","volume":"13","author":"Lovera","year":"2007","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.msard.2026.107922_bib0019","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(24)36413-4","article-title":"Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)","volume":"280","author":"Merlos","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.msard.2026.107922_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-017-2955-7","article-title":"Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients","volume":"430","author":"Morel","year":"2017","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.msard.2026.107922_bib0021","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1007\/s12035-022-02755-0","article-title":"Therapeutic potential of combined therapy of vitamin A and vitamin C in the experimental autoimmune encephalomyelitis (EAE) in Lewis rats","volume":"59","author":"Navidhamidi","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.msard.2026.107922_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.620963","article-title":"Platelets in multiple sclerosis: early and central mediators of inflammation and neurodegeneration and attractive targets for molecular imaging and site-directed therapy","volume":"12","author":"Orian","year":"2021","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2026.107922_bib0023","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2004.01.008","article-title":"Platelet-activating factor acetylhydrolase gene polymorphism and its activity in Japanese patients with multiple sclerosis","volume":"150","author":"Osoegawa","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107922_bib0024","article-title":"Plasma circulating vitamin C levels and risk of multiple sclerosis: a two-sample mendelian randomization analysis","volume":"56","author":"Peng","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2026.107922_bib0025","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1002\/ptr.7050","article-title":"A systematic review of possible interactions for herbal medicines and dietary supplements used concomitantly with disease-modifying or symptom-alleviating multiple sclerosis drugs","volume":"35","author":"Petersen","year":"2021","journal-title":"PhytOther Res."},{"issue":"3","key":"10.1016\/j.msard.2026.107922_bib0026","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/phrs.2001.0808","article-title":"Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor","volume":"44","author":"Qian","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.msard.2026.107922_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.859421","article-title":"Plasmalogenic lipid analogs as platelet-activating factor antagonists: a potential novel class of anti-inflammatory compounds","volume":"10","author":"Rong","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.msard.2026.107922_bib0028","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/bmm.14.9","article-title":"Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis","volume":"8","author":"S\u00e1enz-Cuesta","year":"2014","journal-title":"Biomark. Med."},{"key":"10.1016\/j.msard.2026.107922_bib0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-5-27","article-title":"Evidence of platelet activation in multiple sclerosis","volume":"5","author":"Sheremata","year":"2008","journal-title":"J. Neuroinflammation."},{"issue":"3","key":"10.1016\/j.msard.2026.107922_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058979","article-title":"Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation","volume":"8","author":"Sotnikov","year":"2013","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.msard.2026.107922_bib0031","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/714037693","article-title":"Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes","volume":"40","author":"Stafforini","year":"2003","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"9","key":"10.1016\/j.msard.2026.107922_bib0032","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCRESAHA.115.306847","article-title":"Platelets play differential role during the initiation and progression of autoimmune neuroinflammation","volume":"117","author":"Starossom","year":"2015","journal-title":"Circ. Res."},{"issue":"16","key":"10.1016\/j.msard.2026.107922_bib0033","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.2025.1604","article-title":"High-dose vitamin D in clinically isolated syndrome typical of multiple sclerosis: the d-lay MS randomized clinical trial","volume":"333","author":"Thouvenot","year":"2025","journal-title":"JAMa"},{"issue":"10","key":"10.1016\/j.msard.2026.107922_bib0034","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1007\/s12035-020-02003-3","article-title":"Platelet-activating factor deteriorates lysophosphatidylcholine-induced demyelination via its receptor-dependent and-independent effects","volume":"57","author":"Tian","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.msard.2026.107922_bib0035","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/biof.1916","article-title":"Plasmalogens and platelet-activating factor roles in chronic inflammatory diseases","volume":"48","author":"Tremblay","year":"2022","journal-title":"BioFactors"},{"issue":"3","key":"10.1016\/j.msard.2026.107922_bib0036","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0003319710375089","article-title":"vitro and in vivo effects of statins on platelet-activating factor and its metabolism","volume":"62","author":"Tsantila","year":"2011","journal-title":"Angiology"},{"issue":"9","key":"10.1016\/j.msard.2026.107922_bib0037","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/all.15308","article-title":"Platelet-activating factor acetylhydrolase is a biomarker of severe anaphylaxis in children","volume":"77","author":"Upton","year":"2022","journal-title":"Allergy"},{"issue":"18","key":"10.1016\/j.msard.2026.107922_bib0038","doi-asserted-by":"crossref","first-page":"9915","DOI":"10.3390\/ijms22189915","article-title":"Platelet inhibition by low-dose acetylsalicylic acid reduces neuroinflammation in an animal model of multiple sclerosis","volume":"22","author":"Vogelsang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2026.107922_bib0039","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00001756-200402090-00010","article-title":"Involvement of the NMDA receptor\/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity","volume":"15","author":"Xu","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.msard.2026.107922_bib0040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.intimp.2019.02.035","article-title":"The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation","volume":"70","author":"Yu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.msard.2026.107922_bib0041","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.2147\/DDDT.S251941","article-title":"Effect of platelet-activating factor on barrier function of ARPE-19 cells","volume":"14","author":"Zhang","year":"2020","journal-title":"Drug. Devel. Ther."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:40:13Z","timestamp":1793954413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826009570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S2211034826009570"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107922","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-activating factor in multiple sclerosis: From peripheral inflammation to central neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107922"}}